美光(MU.US)上季多賺逾倍 勝預期
美光(MU.US)截至2月底止第二季非通用會計準則(Non-GAAP)下的盈利增長逾倍至24.44億美元,不計及特殊項目每股盈利爲2.14美元,高於預期的1.97美元。收入增長24.8%至77.9億美元,高於預期的75.2億美元。
美光表示,預計俄烏開戰導致的零件短缺不會對短期生產帶來影響,但預計成本將會上升。公司預計本季度收入爲87億美元,上下浮動2億美元,而分析師平均估計爲80.6億美元。
在業績公佈後,美光股價盤後升近4%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.